{"id":"doi:10.1056/nejmoa2210645","kind":"article","title":"Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk","authors":["Aruna D. Pradhan","Robert J. Glynn","Jean‐Charles Fruchart","Jean G. MacFadyen","Elaine Zaharris","Brendan M. Everett","Stuart E. Campbell","Ryu Oshima","Pierre Amarenco","Dirk Jacobus Blom","Eliot A. Brinton","Robert H. Eckel","Marshall B. Elam","João Soares Felício","Henry N. Ginsberg","Assen Goudev","Shun Ishibashi","Jacob Joseph","Tatsuhiko Kodama","Wolfgang Köenig","Lawrence A. Leiter","Alberto J. Lorenzatti","Boris Mankovsky","Nikolaus Marx","Børge Grønne Nordestgaard"],"author_count":36,"year":2022,"published":"2022-11-05","venue":"New England Journal of Medicine","cited_by":746,"doi":"10.1056/nejmoa2210645","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1056/nejmoa2210645","archive_url":"https://space-kitty.com/papers/doi:10.1056/nejmoa2210645","updated":null,"pmid":"36342113","pmcid":null,"openalex_id":"W4308367139","pdf_url":"https://www.nejm.org/doi/pdf/10.1056/NEJMoa2210645?articleTools=true","abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Lipoproteins and Cardiovascular Health"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"cardiovascular-innovation","name":"Cardiovascular Therapeutics","domain_slug":"medicine"}],"cited_in_dossiers":[]}